A detailed history of Cerity Partners LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Cerity Partners LLC holds 127,071 shares of TAK stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,071
Previous 65,800 93.12%
Holding current value
$1.72 Million
Previous $851,000 112.1%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.0 - $15.08 $796,523 - $923,966
61,271 Added 93.12%
127,071 $1.81 Million
Q2 2024

Aug 13, 2024

SELL
$12.6 - $13.67 $593,094 - $643,460
-47,071 Reduced 41.7%
65,800 $851,000
Q1 2024

May 14, 2024

BUY
$13.89 - $15.04 $693,152 - $750,541
49,903 Added 79.25%
112,871 $1.57 Million
Q4 2023

Jan 26, 2024

SELL
$13.36 - $15.43 $60,868 - $70,299
-4,556 Reduced 6.75%
62,968 $898,000
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $109,734 - $119,152
7,301 Added 12.12%
67,524 $1.04 Million
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $32,261 - $35,451
-2,072 Reduced 3.33%
60,223 $946,000
Q1 2023

May 11, 2023

BUY
$15.28 - $16.48 $111,605 - $120,369
7,304 Added 13.28%
62,295 $1.03 Million
Q4 2022

Feb 15, 2023

SELL
$12.42 - $15.62 $284,865 - $358,260
-22,936 Reduced 29.43%
54,991 $858,000
Q3 2022

Nov 10, 2022

BUY
$12.8 - $28.65 $311,872 - $698,057
24,365 Added 45.49%
77,927 $1.01 Million
Q2 2022

Aug 10, 2022

BUY
$13.12 - $15.03 $280,321 - $321,130
21,366 Added 66.36%
53,562 $752,000
Q1 2022

Apr 25, 2022

BUY
$13.54 - $15.35 $182,884 - $207,332
13,507 Added 72.27%
32,196 $459,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $64,585 - $80,425
4,904 Added 35.57%
18,689 $253,000
Q3 2021

Oct 25, 2021

SELL
$16.3 - $17.26 $554 - $586
-34 Reduced 0.25%
13,785 $226,000
Q2 2021

Aug 11, 2021

SELL
$16.55 - $18.64 $14,597 - $16,440
-882 Reduced 6.0%
13,819 $233,000
Q1 2021

Aug 11, 2021

SELL
$16.71 - $19.9 $161,452 - $192,273
-9,662 Reduced 39.66%
14,701 $268,000
Q1 2021

May 12, 2021

SELL
$16.71 - $19.9 $72,120 - $85,888
-4,316 Reduced 15.05%
24,363 $445,000
Q4 2020

Feb 11, 2021

BUY
$15.39 - $18.97 $11,157 - $13,753
725 Added 2.59%
28,679 $522,000
Q2 2020

Aug 14, 2020

BUY
$14.59 - $19.5 $136,358 - $182,247
9,346 Added 50.23%
27,954 $501,000
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $7,108 - $11,089
546 Added 3.02%
18,608 $282,000
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $14,921 - $18,413
884 Added 5.15%
18,062 $356,000
Q3 2019

Oct 30, 2019

SELL
$16.15 - $17.99 $59,092 - $65,825
-3,659 Reduced 17.56%
17,178 $295,000
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $81,722 - $100,995
-4,929 Reduced 19.13%
20,837 $369,000
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $430,292 - $554,484
25,766 New
25,766 $525,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.